Skip to content

A Study on the Predictive Value of FT3/FT4, TG/HDL-C, and Their Combination for New-Onset Coronary Heart Disease in Postmenopausal Elderly Women

A Study on the Predictive Value of FT3/FT4, TG/HDL-C, and Their Combination for New-Onset Coronary Heart Disease in Postmenopausal Elderly Women

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117717
Enrollment
Unknown
Registered
2026-01-28
Start date
2026-01-28
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Women over the age of 65; 2. All have undergone coronary angiography, and the coronary heart disease diagnosis angiography indicates that the stenosis degree of any coronary artery or its main branch is >= 50%.

Exclusion criteria

Exclusion criteria: 1. History of old myocardial infarction, coronary artery bypass graft surgery, coronary intervention therapy, as well as other organic heart diseases such as heart valve disease, rheumatic heart disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, etc.; 2. Complicated with malignant arrhythmia, severe cardiac and pulmonary dysfunction, liver and kidney dysfunction, rheumatic immune diseases, tumor hematological diseases, etc.; 3. Clinical data is incomplete.

Design outcomes

Primary

MeasureTime frame
Triiodothyronine / Free Thyroxine;Triglycerides/HDL cholesterol;

Countries

China

Contacts

Public ContactJing Zhang

Northern Jiangsu People's Hospital

zhangjingyjs@163.com+86 514 8737 3075

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026